[
    [
        {
            "time": "",
            "original_text": "健帆生物：前三季度净利润同比增长50%",
            "features": {
                "keywords": [
                    "健帆生物",
                    "净利润",
                    "同比增长",
                    "50%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "健帆生物：前三季度净利润同比增长50%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "健帆生物(300529.SZ)第三季度净利润升66.54%至1.87亿元",
            "features": {
                "keywords": [
                    "健帆生物",
                    "第三季度",
                    "净利润",
                    "增长",
                    "66.54%",
                    "1.87亿元"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)第三季度净利润升66.54%至1.87亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【东吴晨报1022】【策略】【行业】汽车【个股】三花智控、健帆生物、锦浪科技",
            "features": {
                "keywords": [
                    "东吴晨报",
                    "策略",
                    "行业",
                    "汽车",
                    "三花智控",
                    "健帆生物",
                    "锦浪科技"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "汽车",
                    "生物医药",
                    "新能源"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【东吴晨报1022】【策略】【行业】汽车【个股】三花智控、健帆生物、锦浪科技",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]